Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mette K Andersen

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Current Diabetes Reports|July 30, 2020
New Insights into the Genetics of Latent Autoimmune Diabetes in AdultsMette K Andersen
Current Opinion in Lipidology|January 10, 2026
Genetic determinants of plasma lipids in GreenlandersJasmin Hjerresen, Emil Jørsboe, Mette K Andersen
Ugeskrift for Laeger|October 28, 2022
Louise Aas Holm, Mette K Andersen, Torben Hansen
Danish Medical Journal|November 29, 2023
Genetics of metabolic traits in GreenlandersAnne Cathrine Baun Thuesen, Mette K Andersen, Torben Hansen
Genes, Chromosomes & Cancer|January 13, 2005
Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH studyMette K Andersen, Debes H Christiansen, Jens Pedersen-Bjergaard
Hematology. American Society of Hematology. Education Program|November 21, 2007
Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJens Pedersen-Bjergaard, Morten T Andersen, Mette K Andersen
Blood|May 15, 2004
Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformationDebes H Christiansen, Mette K Andersen, Jens Pedersen-Bjergaard
Genes, Chromosomes & Cancer|March 3, 2007
Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocationsDebes H Christiansen, Frehiwet Desta, Mette K Andersen, et al.
European Journal of Endocrinology|April 19, 2012
Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia Prospective StudyMette K Andersen, Virve Lundgren, Bo Isomaa, et al.
Blood|March 6, 2002
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemiaJens Pedersen-Bjergaard, Mette K Andersen, Debes H Christiansen, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Current Diabetes Reports|July 30, 2020
New Insights into the Genetics of Latent Autoimmune Diabetes in AdultsMette K Andersen
Current Opinion in Lipidology|January 10, 2026
Genetic determinants of plasma lipids in GreenlandersJasmin Hjerresen, Emil Jørsboe, Mette K Andersen
Ugeskrift for Laeger|October 28, 2022
Louise Aas Holm, Mette K Andersen, Torben Hansen
Danish Medical Journal|November 29, 2023
Genetics of metabolic traits in GreenlandersAnne Cathrine Baun Thuesen, Mette K Andersen, Torben Hansen
Genes, Chromosomes & Cancer|January 13, 2005
Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH studyMette K Andersen, Debes H Christiansen, Jens Pedersen-Bjergaard
Hematology. American Society of Hematology. Education Program|November 21, 2007
Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJens Pedersen-Bjergaard, Morten T Andersen, Mette K Andersen
Blood|May 15, 2004
Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformationDebes H Christiansen, Mette K Andersen, Jens Pedersen-Bjergaard
Genes, Chromosomes & Cancer|March 3, 2007
Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocationsDebes H Christiansen, Frehiwet Desta, Mette K Andersen, et al.
European Journal of Endocrinology|April 19, 2012
Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia Prospective StudyMette K Andersen, Virve Lundgren, Bo Isomaa, et al.
Blood|March 6, 2002
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemiaJens Pedersen-Bjergaard, Mette K Andersen, Debes H Christiansen, et al.
Pageof 10